1,893
Views
47
CrossRef citations to date
0
Altmetric
Original

In Vitro Comparison of Dodecafluoropentane (DDFP), Perfluorodecalin (PFD), and Perfluoroctylbromide (PFOB) in the Facilitation of Oxygen Exchange

, , , &
Pages 156-162 | Published online: 13 Aug 2009

References

  • Dias A.M.A., Freire M., Coutinho J.A.P., Marrucho I.M. Solubility of oxygen in liquid perfluorocarbons. Fluid Phase Equilibria. 2004; 222–223: 325–330
  • Cheung A.T., To P.L., Chan D.M., Ramanujam S., Barbosa M.A., Chen P.C., Driessen B., Jahr J.S., Gunther R.A. Comparison of treatment modalities for hemorrhagic shock. Artif. Cells Blood Substit Immobil. Biotechnol. 2007; 35(2)173–190
  • Schoenberg M.H., Beger H.G. Reperfusion injury after intestinal ischemia. Crit. Care Med. 1993; 21(9)1376–1386
  • Grace P.A. Ischemia-reperfusion injury. Brit. J. Surg. 1994; 81: 637–647
  • Koch C.J., Oprysko P.R., Shuman A.L., Jenkins W.T., Brandt G., Evans S.M. Radiosensitization of hypoxic tumor cells by dodecafluoropentane: a gas-phase perfluorochemical emulsion. Cancer Research. 2002; 62: 3626–3629
  • Lundgren C., Bergoe G., Olszowka A., Tyssebotn I. Tissue nitrogen elimination in oxygen-breathing pigs is enhanced by fluorocarbon-derived intravascular micro-bubbles. UHM 2005; 32(4)215–226
  • Van Liew H.D., Burkard M.E. Relationship of oxygen content to PO2 for stabilized bubbles in the circulation: theory. J. Appl. Physiol. 1996; 81(1)500–508
  • Fagan S.C., Morgenstern L.B., Petitta A., Ward R.E., Tilley B.C., Marler J.R., Levine S.R., Broderick J.P., Kwiatkowski T.G., Frankel M., Brott T.G., Walker M.D. The NINDS rt-PA Stroke Study Group. Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. Neurology. 1998; 50: 883–890
  • Levi C.R. Tissue plasminogen activator (tPA) in acute ischaemic stroke: time for collegiate communication and consensus. The Medical Journal of Australia. 2004; 180(12)634–636
  • Robbin M.L., Eisenfeld A.J. Perflenapent emulsion; a US contrast agent for diagnostic radiology-multicenter, double-blind comparison with a placebo. Radiology. 1998; 207: 717–722
  • Lundgren C., Bergoe G., Olszowka A., Tyssebotn I. Intravascular fluorocarbon-stabilized microbubbles protect against fatal anemia in rats. Artificial Cells, Blood Substitutes, and Biotechnology. 2006; 34(5)473–468
  • Johnson E.C., Erickson B.K., Podolsky A., Birks E.K., Keipert P.E., Faithfull N.S., Wagner P.D. Effects of a perfluorocarbon emulsion for enhanced O2 solubility on hemodynamics and O2 transport in dogs. J. Appl. Physiol. 1995; 79(5)1777–1786
  • Lowe K.C. Fluorinated blood substitutes and oxygen carriers. Journal of Fluorine Chemistry. 2001; 109: 59–65
  • Leese P.T., Noveck R.J., Shorr J.S., Woods C.M., Flaim K.E., Keipert P.E. Randomized safety studies of intravenous perflubron emulsion. I. Effects on coagulation function in healthy volunteers. Anesth. Analg. 2000; 91: 804–811
  • Wahr J.A., Trouwborst A., Spence R.K., Henny C.P., Ceraianu A.C., Graziano G.P., Tremper K.K., Flaim K.E., Faithfull N.S., Clymer J.J. A pilot study of the effects of a perflubron emulsion, AF 0104, on mixed venous oxygen tension in anesthetized surgical patients. Anesth. Analg. 1996; 82: 103–107
  • Kiral, R.M., Nicora, R., Evitts, D.P. 2002. Comparison of oxygen carrying capacity of a new perfluorocarbon (pfc) blood substitute in rats breathing room air or 100% oxygen. Presented at:. APS Intersociety Meeting, San Diego, CA.
  • Dias A.M.A., Goncalves C.M.B., Legido J.L., Coutinho J.A.P., Marrucho I.M. Solubility of oxygen in substituted perfluorocarbons. Fluid Phase Equilibria. 2005; 238: 7–12
  • Krafft M.P. Fluorocarbons and fluorinated amphiphiles in drug delivery and biomedical research. Advanced Drug Delivery Reviews 2001; 47: 209–228
  • Flaim S.F. Pharmacokinetics and side effects of perfluorocarbon-based blood substitutes. Art. Cells, Blood Subst., Immob. Biotech. 1994; 22: 1043–1054
  • Tremper K.K. Perfluorochemical blood substitutes. Anesthesiology. 1999; 91: 1185–1187
  • Burkard M.E., Van Liew H.D. Oxygen transport to tissues by persistent bubbles: theory and simulations. J. Appl. Physiol. 1994; 77: 2874–2878
  • Takanori Y., Schmid-Schönbein G.W., Cotter B., DeMaria A.N. Flow dynamics of QW7437, a new dodecafluoropentane ultrasound contrast agent, in the microcirculation. J. Amer. Coll. Cardiology 1999; 34(2)578–586
  • Correas J.M., Meuter A.R., Singlas E., Kessler D.R., Worah D., Quay S.C. Human pharmacokinetics of a perfluorocarbon ultrasound contrast agent evaluated with gas chromatography. Ultrasound in Med. Biol. 2001; 27(4)565–570
  • Riess J.G. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Aritficial Cells, Blood Substitutes, and Biotechnology 2005; 33: 47–63
  • Van Liew H.D., Burkard M.E. Bubbles in circulating blood: stabilization and simulations of cyclic changes of size and content. J. Appl. Physiol. 1995; 79(4)1379–1385
  • Van Liew H.D., Raychaudhuri S. Stabilized bubbles in the body: pressure-radius relationships and the limits to stabilization. J. Appl. Physiol. 1997; 82: 2045–2053
  • Van Liew H.D., Burkard M.E. Behavior of bubbles of slowly permeating gas used for ultrasonic imaging contrast. Investigative Radiology 1995; 30(5)315–321
  • Kerschen, A. 2007. Universal COM Logger software (communications port data logger), Tucson, AZ.
  • Lowe K.C. Perfluorochemicals in medicine. Chemistry and Industry 1991; 3(83)1–6
  • Toft K.G., Hustvedt S.O., Hals P.A., Oulie I., Uran S., Landmark K, Normann P.T., Skotland T. Disposition of perfluorobutane in rats after intravenous injection of Sonazoid. Ultrasound in Med. Biol. 2006; 32(1)107–114

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.